CellNovo Company
CellNovo believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition.
Industry:
Geroscience
Headquarters:
Wales, Cumbria, United Kingdom
Zip:
51-100
Founded Date:
2002-01-01
Employees Number:
51-100
Acquisitions Number:
10
Investors Number:
102536701
Total Funding:
$1M to $10M
Estimated Revenue:
2015-07-17
Last Funding Date:
Post-IPO Debt
Last Funding Type:
info@cellnovo.com
Register and Claim Ownership